Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 505-515
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.505
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.505
Characteristics | Patients (n = 1868) |
Mean age (range), yr | 65 (28-93) |
Gender | |
Male | 1072 (57.4) |
Female | 796 (42.6) |
Location | |
Colon | 892 (47.8) |
Rectum | 957 (51.2) |
Unknown | 19 (1.0) |
Histology | |
Well differentiated | 484 (25.9) |
Moderate differentiated | 1066 (57.1) |
Poorly differentiated | 139 (7.4) |
Unknown | 179 (9.6) |
Tumor stage | |
I | 281 (15.0) |
II | 551 (29.5) |
III | 667 (35.7) |
IV | 369 (19.8) |
Chemotherapy | |
No | 294 (15.8) |
Yes | 1574 (84.2) |
- Citation: Kim JH, Lee JY, Kim HK, Lee JW, Jung SG, Jung K, Kim SE, Moon W, Park MI, Park SJ. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer. World J Gastroenterol 2017; 23(3): 505-515
- URL: https://www.wjgnet.com/1007-9327/full/v23/i3/505.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i3.505